•Dual roles of complement in ulcerative colitis: insights from clinical studies and animal research
•Ustekinumab may have therapeutic effects on autoimmune thyroid disease
•Integrative multi-omics analysis identifies genetically supported druggable targets for inflammatory bowel disease
•Burden of primary sclerosing cholangitis in Sweden (2002-2020): Incidence, outcomes, healthcare utilization, and costs
•Therapy de-escalation in pediatric patients with inflammatory bowel disease in remission: Data analysis from the CEDATA registry